ARCHER TIMOTHY 4
4 · LAM RESEARCH CORP · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Lam Research CEO Timothy Archer Sells 30,000 Shares
What Happened
Timothy Archer, President & CEO of Lam Research (LRCX), exercised 30,000 options (strike/consideration $30.03) to acquire shares and immediately sold 30,000 shares in an open-market transaction on July 2, 2026. The exercise cost was $900,990 (30,000 × $30.03); the subsequent sale fetched approximately $11,700,300 (30,000 × $390.01). The filing also shows a separate derivative disposition of 30,000 shares at $0 on the same date (see Key Details).
Key Details
- Transaction date: July 2, 2026
- Exercise: 30,000 shares acquired at $30.03 — total $900,990
- Sale: 30,000 shares sold on open market at $390.01 — proceeds ~$11,700,300
- Derivative disposition: 30,000 shares reported disposed at $0 (filing does not fully explain this line)
- Shares owned after transaction: Not specified in the filing
- Footnotes from filing:
- F1: Trade effected pursuant to a Rule 10b5-1 trading plan adopted Feb 24, 2026
- F2: Reported amount includes shares subject to unvested restricted stock units
- F3: The stock options referenced became exercisable in three installments (03/02/2021, 03/02/2022, 03/02/2023)
- Filing date: July 6, 2026 (reports the July 2 transaction)
Context
This was an exercise of options followed by an immediate sale of the resulting shares — effectively a cashless exercise and sale on the same day. The sale was made under a pre-established 10b5-1 plan, which typically means the trade was preplanned rather than a discretionary, on-the-spot decision. The filing does not indicate any late-reporting flag.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1][F2]2026-07-02$30.03/sh+30,000$900,990→ 1,105,966 total - Sale
Common Stock
[F1][F2]2026-07-02$390.01/sh−30,000$11,700,300→ 1,075,966 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F3]2026-07-02−30,000→ 91,400 totalExercise: $30.03Exp: 2027-03-02→ Common Stock (30,000 underlying)
- 48,025.745(indirect: By 401(k))
Common Stock
- 5,670.026(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
- [F2]The amount reported includes shares subject to unvested restricted stock units.
- [F3]The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.